We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bio-Rad Acquires Scottish Diagnostic Company

By HospiMedica staff writers
Posted on 17 Apr 2002
In a move that expands its line of tests for genetic disorders, Bio-Rad Laboratories, Inc. More...
(Hercules, CA, USA) has acquired Quantase Neonatal Diagnostics, Ltd. (Perth, Scotland). Terms were not disclosed.

Quantase specializes in diagnostic products for newborn screening. The acquisition strengthens Bio-Rad as a supplier of newborn screening tests for phenylketonuria, galactosemia, and glucose-6-phosphate dehydrogenase deficiency. It also enhances the company's position in genetic testing by adding to its portfolio of DNA, immunoassay, and high perfusion liquid chromatography (HPLC) tests for sickle cell anemia, metabolic disorders, and thalassemia.

"This acquisition strengthens our position in serving the genetic screening market and provides a foundation for us to further our innovation in genetic screening products and services,” said David Schwartz, president of Bio-Rad. "Quantase has an excellent reputation for quality products and broad customer acceptance throughout the world.”




Related Links:
Bio-Rad

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.